That’s partially because many phosphosites who have opposite, antagonistic functions to the activate sites were hypophosphorylated in cancer cells, for example S141 in PAK2 and S43 and S296 in RAF1 in the MAPK pathway. The gene discussed is RAF1; the disease is cancer.